Morningstar Investment Services LLC Alnylam Pharmaceuticals, Inc. Transaction History

Morningstar Investment Services LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$120.42 - $169.29 $10.1 Million - $14.2 Million	-83,831 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$127.18 - $173.91 $160,755 - $219,822	1,264 Added 1.53%	83,831 $13.9 Million
Q4 2021 Feb 01, 2022	BUY	$159.56 - $209.29 $314,811 - $412,929	1,973 Added 2.45%	82,567 $14 Million
Q3 2021 Nov 12, 2021	BUY	$169.75 - $207.73 $242,233 - $296,430	1,427 Added 1.8%	80,594 $14.3 Million
Q2 2021 Aug 12, 2021	BUY	$128.63 - $176.89 $336,624 - $462,921	2,617 Added 3.42%	79,167 $13.1 Million
Q1 2021 May 11, 2021	BUY	$126.83 - $175.69 $9.71 Million - $13.4 Million	76,550 New	76,550 $10.3 Million

641

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Morningstar Investment Services LLC, based on Form 13F filings with the SEC.

Stay updated on Morningstar Investment Services LLC with notifications on news.